Ghamari M, Jabalameli F, Emaneini M, Beigverdi R
New Microbes New Infect. 2022; 45:100957.
PMID: 35198219
PMC: 8851280.
DOI: 10.1016/j.nmni.2022.100957.
Kaminska D, Ratajczak M, Szumala-Kakol A, Dlugaszewska J, Nowak-Malczewska D, Gajecka M
Pathogens. 2020; 9(7).
PMID: 32610654
PMC: 7400139.
DOI: 10.3390/pathogens9070526.
Saed H, Ibrahim H
J Adv Vet Anim Res. 2020; 7(2):186-197.
PMID: 32607349
PMC: 7320817.
DOI: 10.5455/javar.2020.g409.
Gizachew M, Tiruneh M, Moges F, Adefris M, Tigabu Z, Tessema B
BMC Pediatr. 2018; 18(1):378.
PMID: 30501616
PMC: 6271408.
DOI: 10.1186/s12887-018-1350-1.
Haenni M, Lupo A, Madec J
Microbiol Spectr. 2018; 6(2).
PMID: 29600772
PMC: 11633561.
DOI: 10.1128/microbiolspec.ARBA-0008-2017.
Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections.
Lewis 2nd J, Lepak A, Thompson 3rd G, Craig W, Andes D, Sabol-Dzintars K
Antimicrob Agents Chemother. 2013; 58(3):1327-31.
PMID: 24323478
PMC: 3957897.
DOI: 10.1128/AAC.01877-13.
Antibiotic susceptibility patterns and prevalence of group B Streptococcus isolated from pregnant women in Misiones, Argentina.
Quiroga M, Pegels E, Oviedo P, Pereyra E, Vergara M
Braz J Microbiol. 2013; 39(2):245-50.
PMID: 24031210
PMC: 3768385.
DOI: 10.1590/S1517-83822008000200009.
Environmental impact assessment of Attenda abattoir, Ogbomoso southwestern Nigeria on surface and groundwater quality using geo-electrical imaging and microbiological analysis.
Adelowo O, Akinlabi I, Fagade O
Environ Monit Assess. 2011; 184(7):4565-74.
PMID: 22105848
DOI: 10.1007/s10661-011-2285-2.
Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations.
Bowling J, Owens A, McElmeel M, Fulcher L, Herrera M, Wickes B
J Clin Microbiol. 2010; 48(6):2275-7.
PMID: 20392918
PMC: 2884503.
DOI: 10.1128/JCM.00663-10.
Invasive group B streptococcal infection in infants, Malawi.
Gray K, Bennett S, French N, Phiri A, Graham S
Emerg Infect Dis. 2007; 13(2):223-9.
PMID: 17479883
PMC: 2725867.
DOI: 10.3201/eid1302.060680.
Prenatal culture-based screening of Streptococcus agalactiae colonisation: resistance against erythromycin and clindamycin.
Lavergne V, Laverdiere M, Duchesne A, Beliveau C, Delorme J, Di Zazzo A
Eur J Clin Microbiol Infect Dis. 2006; 25(8):532-4.
PMID: 16874484
DOI: 10.1007/s10096-006-0180-5.
Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources.
Duarte R, Bellei B, Miranda O, Brito M, Teixeira L
Antimicrob Agents Chemother. 2004; 49(1):97-103.
PMID: 15616281
PMC: 538850.
DOI: 10.1128/AAC.49.1.97-103.2005.
Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany.
Fluegge K, Supper S, Siedler A, Berner R
Antimicrob Agents Chemother. 2004; 48(11):4444-6.
PMID: 15504878
PMC: 525390.
DOI: 10.1128/AAC.48.11.4444-4446.2004.
Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital.
Acikgoz Z, Almayanlar E, Gamberzade S, Gocer S
Antimicrob Agents Chemother. 2004; 48(4):1410-2.
PMID: 15047555
PMC: 375322.
DOI: 10.1128/AAC.48.4.1410-1412.2004.
Six-month multicenter study on invasive infections due to group B streptococci in Argentina.
Lopardo H, Vidal P, Jeric P, Centron D, Paganini H, Facklam R
J Clin Microbiol. 2003; 41(10):4688-94.
PMID: 14532204
PMC: 254350.
DOI: 10.1128/JCM.41.10.4688-4694.2003.
Antimicrobial susceptibilities of group B streptococci in New Zealand.
Werno A, Anderson T, Murdoch D
Antimicrob Agents Chemother. 2003; 47(8):2710-1.
PMID: 12878549
PMC: 166078.
DOI: 10.1128/AAC.47.8.2710-2711.2003.
Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci.
Diekema D, Andrews J, Huynh H, Rhomberg P, Doktor S, Beyer J
J Clin Microbiol. 2003; 41(6):2659-61.
PMID: 12791897
PMC: 156484.
DOI: 10.1128/JCM.41.6.2659-2661.2003.
Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae.
Betriu C, Culebras E, Gomez M, Rodriguez-Avial I, Sanchez B, Agreda M
Antimicrob Agents Chemother. 2003; 47(3):1112-4.
PMID: 12604549
PMC: 149330.
DOI: 10.1128/AAC.47.3.1112-1114.2003.
Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital.
Poyart C, Jardy L, Quesne G, Berche P, Trieu-Cuot P
Antimicrob Agents Chemother. 2003; 47(2):794-7.
PMID: 12543695
PMC: 151750.
DOI: 10.1128/AAC.47.2.794-797.2003.
Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae.
Culebras E, Rodriguez-Avial I, Betriu C, Redondo M, Picazo J
Antimicrob Agents Chemother. 2002; 46(5):1574-6.
PMID: 11959603
PMC: 127186.
DOI: 10.1128/AAC.46.5.1574-1576.2002.